Search for: "Johnson v. GlaxoSmithKline"
Results 21 - 40
of 48
Sorted by Relevance
|
Sort by Date
15 Aug 2007, 7:49 am
Hendleson v. [read post]
27 Oct 2010, 12:17 pm
Yohn Jr. in Teva v. [read post]
6 Apr 2015, 2:37 pm
Johnson, 2015 U.S. [read post]
29 May 2014, 5:39 am
V. [read post]
22 Oct 2008, 11:48 pm
Stores Co., 143 Cal.App.4th 1223 (2006) with their decision in Johnson v. [read post]
16 Sep 2018, 10:54 am
Johnson & Johnson, No. 09-cv-04124, 2014 WL 2943572, at *5 (N.D. [read post]
11 Jun 2013, 10:50 am
But the roles were reversed in the diversity jurisdiction dispute addressed by the Third Circuit in Johnson v. [read post]
18 Jun 2012, 1:38 pm
Christopher v. [read post]
17 Jun 2011, 2:04 pm
See Johnson v. [read post]
25 Feb 2011, 8:00 am
In Christopher v. [read post]
16 Oct 2006, 7:58 pm
GlaxoSmithKline and Dr. [read post]
5 Mar 2024, 10:55 am
Since 2019, the following pharmaceutical manufacturers have posted seven or more notices of correction: Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novo Nordisk, and Purdue Pharmaceuticals. [read post]
14 Nov 2016, 9:16 am
Civil Procdedure – Final Judgment: Johnson & Johnson Vision Care, Inc. v. [read post]
30 Jan 2020, 2:35 pm
In today’s decision in Generics (UK) v. [read post]
23 Dec 2008, 1:00 pm
Johnson v. [read post]
8 Feb 2017, 3:09 am
Apple Inc., No. 16-651 Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
16 Jan 2017, 5:44 pm
Apple Inc., No. 16-651 Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
16 Jun 2011, 12:58 pm
See Johnson v. [read post]
1 Feb 2013, 9:42 am
GlaxoSmithKline, PLC, 737 F. [read post]
3 Sep 2015, 6:36 am
Health Ctr. v. [read post]
